Skip to content

Electroencephalogram (EEG) in General Anaesthesia - More Than Only a Bispectral Index (BIS)

Recovery From Propofol Anaesthesia Guided by Frontal EEG Wave Analysis Compared to Bispectral Index Monitoring Alone in Laparoscopic Surgery: A Multicentre Double-blind Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04105660
Enrollment
232
Registered
2019-09-26
Start date
2021-07-01
Completion date
2022-06-30
Last updated
2023-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Brief summary

Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia.

Detailed description

Processed electroencephalogram (EEG) monitors are routinely used in addition to clinical parameters to assess the depth of anaesthesia during general anaesthesia. In addition to the bispectral (BIS) index displayed as an index, the raw frontal EEG can be displayed as a curve on these monitors. After a short training, anaesthetists might be more accurate and faster in assessing depth of anaesthesia by recognizing the pattern of the EEG curve than by using the BIS index. This may further enhance the positive effects that could be demonstrated for the use of BIS monitors. Therefore, the aim of the investigator's study is to investigate the clinical relevance of interpreting the raw frontal EEG in addition to only using the BIS index for titrating intravenous anaesthetics.

Interventions

OTHERTraining for EEG monitoring

Training for reading EEG curves during anaesthesia

Standard monitoring including clinical parameters and BIS index

Sponsors

Cantonal Hospital of Graubünden, Chur, Switzerland
CollaboratorUNKNOWN
University Hospital, Geneva
CollaboratorOTHER
University Hospital, Basel, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients undergoing in-hospital laparoscopic abdominal surgery with general anaesthesia using Propofol based on the Schnider model (target controlled infusion)42, 43 * Minimal duration of surgery of 60 minutes * Written informed consent

Exclusion criteria

* Same-day surgery * Language barrier * Patients under 18 years of age * Pregnancy (using a beta-human chorionic gonadotropin (HCG) measurement in a blood sample of women in childbearing age) * Allergy to Propofol * Administration of hypnotics other than Propofol, such as ketamine or midazolam preoperatively or intraoperatively * Known brain pathology, such as seizure disorders, dementia, cerebrovascular disease or brain death

Design outcomes

Primary

MeasureTime frameDescription
Quality of recovery (QoR): QoR-15 scale24 hours after surgeryQoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)

Secondary

MeasureTime frameDescription
Quality of recovery (QoR): QoR-15 scale48 hours after surgeryQoR-15 scale (scale from 0 to 150; 0 means best, 150 worst recovery)
Time spent in postanaesthesia care unit (PACU)At arrival to and at discharge from postanaesthesia care unit (an average of 120 minutes)Time in minutes from arrival in PACU until discharge from PACU
Time to extubationAt time of skin closure and at time of extubation (an average of 90 minutes)Time in minutes from skin closure to extubation
Propofol consumptionduring anaesthesiaPropofol consumption in mg/kg/h
Aldrete scoreOnce at discharge from postanaesthesia care unit (PACU), approximately on day 2 of admission to hospitalMeasurement of recovery; score is 0 to 10, 0 means worst recovery, 10 means best recovery
Incidence of Postoperative Nausea and Vomiting (PONV)daily from admission up to hospital discharge, an average of approximately 14 daysIncidence of nausea and vomiting daily until hospital discharge
Risk of awarenessdaily from admission up to hospital discharge, an average of approximately 14 daysBrice interview daily until hospital discharge

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026